The DOI matches its Crossref record; 23 of the 25 references it cites were found in a registry or an index.
Monetary Costs of Dementia in the United States
Open accessAbstract
BACKGROUND: Dementia affects a large and growing number of older adults in the United States. The monetary costs attributable to dementia are likely to be similarly large and to continue to increase. METHODS: In a subsample (856 persons) of the population in the Health and Retirement Study (HRS), a nationally representative longitudinal study of older adults, the diagnosis of dementia was determined with the use of a detailed in-home cognitive assessment that was 3 to 4 hours in duration and a review by an expert panel. We then imputed cognitive status to the full HRS sample (10,903 persons, 31,936 person-years) on the basis of measures of cognitive and functional status available for all HRS respondents, thereby identifying persons in the larger sample with a high probability of dementia. The market costs associated with care for persons with dementia were determined on the basis of self-reported out-of-pocket spending and the utilization of nursing home care; Medicare claims data were used to identify costs paid by Medicare. Hours of informal (unpaid) care were valued either as the cost of equivalent formal (paid) care or as the estimated wages forgone by informal caregivers. RESULTS: The estimated prevalence of dementia among persons older than 70 years of age in the United States in 2010 was 14.7%. The yearly monetary cost per person that was attributable to dementia was either $56,290 (95% confidence interval [CI], $42,746 to $69,834) or $41,689 (95% CI, $31,017 to $52,362), depending on the method used to value informal care. These individual costs suggest that the total monetary cost of dementia in 2010 was between $157 billion and $215 billion. Medicare paid approximately $11 billion of this cost. CONCLUSIONS: Dementia represents a substantial financial burden on society, one that is similar to the financial burden of heart disease and cancer. (Funded by the National Institute on Aging.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Annual incremental health care and nursing home costs for individuals with dementia are estimated at $28,501 per person per year in 2010 dollars ($40,023 in 2022 dollars).A16,714”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [714]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Annual incremental health care and nursing home costs for individuals with dementia (that is, the additional costs compared with those for individuals without dementia) are estimated at $28,501 per person per year in 2010 dollars ($40,209 in 2023 dollars).A16 , 858”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [858]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The costs of health care and long-term care for individuals with Alzheimer's or other dementias are substantial, and dementia is one of the costliest conditions to society.714”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [714]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Agitation is common, persistent, difficult to treat, costly, and associated with severe adverse consequences for patients and caregivers1–5.”
From Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,846
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Self-citationBrookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
Telephone Interview for Cognitive Status
Brandt, J., Spencer, M., & Folstein, M. F. (1988) · PsycTESTS Dataset · doi:10.1037/t28542-000 · Cited by 1,504
An Overview of the Health and Retirement Study
Juster, F., & Suzman, R. (1995) · The Journal of Human Resources · doi:10.2307/146277 · Cited by 1,476
Measurement Error in Survey Data
Bound, J., Brown, C., & Mathiowetz, N. A. (2001) · Handbook of econometrics · doi:10.1016/s1573-4412(01)05012-7 · Cited by 1,366
Jorm, A. F. (1994) · Psychological Medicine · doi:10.1017/s003329170002691x · Cited by 1,198
2010 Alzheimer's disease facts and figures
Alzheimer's Association (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.01.009 · Cited by 703
Flagged first, then by citations
2 of the 25 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Brandt J, 1988, Neuropsychiatry Neuropsychol Behav Neurol, 1, 111
- Welsh KA, 1993, Neuropsychiatry Neuropsychol Behav Neurol, 6, 103
- Plassman BL, 1994, Neuropsychiatry Neuropsychol Behav Neurol, 7, 235
Cited by
Sorted by citations
Items 101–200 of 1,001
Stall, N. M., Kim, S. J., Hardacre, K. A., Shah, P. S., Straus, S. E., Bronskill, S. E., Lix, L. M., Bell, C. M., & Rochon, P. A. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15690 · Cited by 177
Epidemiology of Idiopathic Normal Pressure Hydrocephalus: A Systematic Review of the Literature
Laez, R. M., Caballero-Arzapalo, H., López, L. Á. S., Arango‐Lasprilla, J. C., & Vázquez-Barquero, A. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.07.005 · Cited by 177
Cognitive impairment in the U.S.: Lifetime risk, age at onset, and years impaired
Hale, J. M., Schneider, D. C., Mehta, N. K., & Myrskylä, M. (2020) · SSM - Population Health · doi:10.1016/j.ssmph.2020.100577 · Cited by 175
The present and future of pharmacotherapy of Alzheimer's disease: a comprehensive review
Anand, A., Patience, A. A., Sharma, N., & Khurana, N. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.043 · Cited by 174
A Pain Research Agenda for the 21st Century
Gereau, R. W., Sluka, K. A., Maixner, W. D., Savage, S. R., Price, T. J., Murinson, B. B., Sullivan, M. D., & Fillingim, R. B. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.09.004 · Cited by 172
Hughes, T. B., Black, B. S., Albert, M., Gitlin, L. N., Johnson, D. M., Lyketsos, C. G., & Samus, Q. M. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001240 · Cited by 171
Societal and Family Lifetime Cost of Dementia: Implications for Policy
Jutkowitz, E., Kane, R. L., Gaugler, J. E., MacLehose, R. F., Dowd, B., & Kuntz, K. M. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15043 · Cited by 164
Voss, M. W., Carr, L. J., Clark, R., & Weng, T. (2014) · Mental health and physical activity · doi:10.1016/j.mhpa.2014.01.001 · Cited by 164
T-cell aging in rheumatoid arthritis
Weyand, C. M., Yang, Z., & Goronzy, J. J. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000011 · Cited by 164
Alzheimer Disease and Its Growing Epidemic
Hickman, R. A., Faustin, A., & Wısnıewskı, T. (2016) · Neurologic Clinics · doi:10.1016/j.ncl.2016.06.009 · Cited by 163
Long-term Risk of Dementia in Persons With Schizophrenia
Ribe, A. R., Laursen, T. M., Charles, M., Katon, W. J., Fenger‐Grøn, M., Davydow, D. S., Chwastiak, L., Cerimele, J. M., & Vestergaard, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1546 · Cited by 162
Psychiatric Disorders and Major Spine Surgery
Menendez, M. E., Neuhaus, V., Bot, A. G. J., Ring, D., & Cha, T. D. (2013) · Spine · doi:10.1097/brs.0000000000000064 · Cited by 161
Iadecola, C., Smith, E. E., Anrather, J., Gu, C., Mishra, A., Misra, S., Pérez‐Pinzón, M. A., Shih, A. Y., Sorond, F. A., van Veluw, S. J., et al. (2023) · Stroke · doi:10.1161/str.0000000000000431 · Cited by 161
Park, J. H., Cho, H. E., Kim, J. H., Wall, M. M., Stern, Y., Lim, H., Yoo, S., Kim, H. S., & Cha, J. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0256-0 · Cited by 156
Drabo, E. F., Barthold, D., Joyce, G., Ferido, P., Chang Chui, H., & Zissimopoulos, J. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.005 · Cited by 155
Pharmacotherapy for Vascular Cognitive Impairment
Farooq, M. U., Min, J., Goshgarian, C., & Gorelick, P. B. (2017) · CNS Drugs · doi:10.1007/s40263-017-0459-3 · Cited by 154
Secular Trends in Dementia and Cognitive Impairment of U.S. Rural and Urban Older Adults
Weden, M. M., Shih, R. A., Kabeto, M. U., & Langa, K. M. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.10.021 · Cited by 153
Self-citationThe economic cost of dementia: A systematic review
Cantarero, D., Lanza‐León, P., Blázquez‐Fernández, C., Sánchez‐Juan, P., & Sarabia‐Cobo, C. (2019) · Dementia · doi:10.1177/1471301219837776 · Cited by 152
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
Ross, E. L., Weinberg, M. S., & Arnold, S. E. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0315 · Cited by 151
Fredriksen-Goldsen, K. I., Jen, S., Bryan, A. E. B., & Goldsen, J. (2018) · Journal of Applied Gerontology · doi:10.1177/0733464816672047 · Cited by 148
Nagaraj, S., Laskowska-Kaszub, K., Dębski, K. J., Wojsiat, J., Dąbrowski, M., Gabryelewicz, T., Kuźnicki, J., & Wojda, U. (2017) · Oncotarget · doi:10.18632/oncotarget.15109 · Cited by 148
Hampel, H., O’Bryant, S. E., Durrleman, S., Younesi, E., Rojkova, K., Escott-Price, V., Corvol, J.-C., Broich, K., Dubois, B., Lista, S., et al. (2017) · Climacteric · doi:10.1080/13697137.2017.1287866 · Cited by 147
The Myth Regarding the High Cost of End-of-Life Care
Aldridge, M. D., & Kelley, A. S. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302889 · Cited by 147
Cohen, R. A., Marsiske, M., & Smith, G. E. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00010-8 · Cited by 150
Bhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00369 · Cited by 145
Shi, Q., Liu, S., Fonseca, V. A., Thethi, T. K., & Shi, L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024954 · Cited by 144
Da, X., Toledo, J. B., Zee, J., Wolk, D. A., Xie, S. X., Ou, Y., Shacklett, A., Parmpi, P., Shaw, L. M. J., Trojanowski, J. Q., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.11.010 · Cited by 144
Opportunity costs of ambulatory medical care in the United States.
Ray, K. N., Chari, A. V., Engberg, J., Bertolet, M. H., & Mehrotra, A. (2015) · PubMed · Cited by 143
Family-Provided Health Care for Children With Special Health Care Needs
Romley, J. A., Shah, A. K., Chung, P. J., Elliott, M. N., Vestal, K. D., & Schuster, M. A. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1287 · Cited by 142
Tewari, D., Stankiewicz, A. M., Mocan, A., Sah, A. N., Tzvetkov, N. T., Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00003 · Cited by 142
Wübker, A., Zwakhalen, S. M. G., Challis, D., Suhonen, R., Karlsson, S., Zabalegui, A., Soto, M., Saks, K., & Sauerland, D. (2014) · The European Journal of Health Economics · doi:10.1007/s10198-014-0620-6 · Cited by 141
The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review
Oliva, J., Trapero‐Bertran, M., Peña-Longobardo, L. M., & Rubio, R. D. P. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0468-y · Cited by 141
Zhu, C. W., Scarmeas, N., Ornstein, K., Albert, M., Brandt, J., Blacker, D., Sano, M., & Stern, Y. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.018 · Cited by 137
Gianattasio, K. Z., Wu, Q., Glymour, M. M., & Power, M. C. (2018) · Epidemiology · doi:10.1097/ede.0000000000000945 · Cited by 137
Retirement and cognitive decline. A longitudinal analysis using SHARE data
Celidoni, M., Bianco, C. D., & Weber, G. (2017) · Journal of Health Economics · doi:10.1016/j.jhealeco.2017.09.003 · Cited by 136
Dementia, Alzheimer’s Disease, and Mortality after Hemodialysis Initiation
McAdams‐DeMarco, M., Daubresse, M., Bae, S., Gross, A. L., Carlson, M. C., & Segev, D. L. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10150917 · Cited by 134
Prevalence and Severity of Dementia in Nursing Home Residents
Helvik, A., Engedal, K., Benth, J. Š., & Selbæk, G. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000433525 · Cited by 133
Kamal, M. S., Northcote, A., Chowdhury, L., Dey, N., Crespo, R. A. G., & Herrera‐Viedma, E. (2021) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2021.3107056 · Cited by 131
Ailshire, J., Karraker, A., & Clarke, P. J. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.11.019 · Cited by 129
Jennings, L. A., Laffan, A. M., Schlissel, A. C., Colligan, E., Tan, Z., Wenger, N. S., & Reuben, D. B. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5579 · Cited by 128
Epigenomics of Alzheimer's disease
Bennett, D. A., Yu, L., Yang, J., Srivastava, G. P., Aubin, C., & Jager, P. L. D. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.006 · Cited by 126
Economic Burden of Disease-Associated Malnutrition at the State Level
Goates, S., Du, K., Braunschweig, C. A., & Arensberg, M. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161833 · Cited by 126
Deardorff, W. J., & Grossberg, G. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s86463 · Cited by 125
Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities
Reitz, C. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1002469 · Cited by 125
Spousal Caregivers Are Caregiving Alone In The Last Years Of Life
Ornstein, K. A., Wolff, J. L., Bollens-Lund, E., Rahman, O.-K., & Kelley, A. S. (2019) · Health Affairs · doi:10.1377/hlthaff.2019.00087 · Cited by 123
Bayesian networks for interpretable machine learning and optimization
Mihaljević, B., Bielza, C., & Larrañaga, P. (2021) · Neurocomputing · doi:10.1016/j.neucom.2021.01.138 · Cited by 123
The social and economic burden of frontotemporal degeneration
Galvin, J. E., Howard, D. H., Denny, S. S., Dickinson, S. L.-J., & Tatton, N. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004614 · Cited by 123
Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease
Gurney, M. E., D'Amato, E. C., & Burgin, A. B. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0309-7 · Cited by 121
Public beliefs and knowledge about risk and protective factors for Alzheimer's disease
Roberts, J. S., McLaughlin, S. J., & Connell, C. M. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.07.001 · Cited by 121
Nagaraj, S., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.008 · Cited by 123
Contributions of Aging to Cerebral Small Vessel Disease
Silva, T. M. D., & Faraci, F. M. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034338 · Cited by 121
Alzheimer's disease and automatic speech analysis: A review
Pulido, M. L. B., Hernández, J. B. A., Ballester, M. Á. F., González, C. M. T., Mekyska, J., & Smékal, Z. (2020) · Expert Systems with Applications · doi:10.1016/j.eswa.2020.113213 · Cited by 120
Trammell, J. P., MacRae, P. G., Davis, G. L., Bergstedt, D., & Anderson, A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00364 · Cited by 120
Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease
Ramanan, V. K., Armstrong, M. J., Choudhury, P., Coerver, K. A., Hamilton, R. H., Klein, B. C., Wolk, D. A., Wessels, S. R., & Jones, L. K. (2023) · Neurology · doi:10.1212/wnl.0000000000207757 · Cited by 120
Treatments for Alzheimer's disease emerge
Selkoe, D. J. (2021) · Science · doi:10.1126/science.abi6401 · Cited by 117
Korecka, M., Waligórska, T., Figurski, M., Toledo, J. B., Arnold, S. E., Grossman, M., Trojanowski, J. Q., & Shaw, L. M. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132489 · Cited by 117
Heart Failure and Risk of Dementia: A Danish Nationwide Population-Based Cohort Study
Adelborg, K., Horváth–Puhó, E., Ording, A. G., Pedersen, L. H., Sørensen, H. T., & Henderson, V. W. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.631 · Cited by 116
Gene therapy for neurological disorders: challenges and recent advancements
Peña, S., Iyengar, R., Eshraghi, R. S., Bencie, N., Mittal, J., Aljohani, A., Mittal, R., & Eshraghi, A. A. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1630415 · Cited by 116
Ijaopo, E. O. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.199 · Cited by 114
Handgrip Strength Is Associated with Poorer Cognitive Functioning in Aging Americans
McGrath, R., Robinson‐Lane, S. G., Cook, S. B., Clark, B. C., Herrmann, S. D., O’Connor, M. L., & Hackney, K. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190042 · Cited by 114
Rembach, A., Watt, A. D., Wilson, W. J., Rainey‐Smith, S. R., Ellis, K. A., Rowe, C. C., Villemagne, V. L., Macaulay, S. L., Bush, A. I., Martins, R. N., et al. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.05.005 · Cited by 113
Effects of Alzheimer Disease on Patients and Their Family
Grabher, B. J. (2018) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.118.218057 · Cited by 112
Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results
Largent, E. A., Harkins, K. A., van Dyck, C. H., Hachey, S. M., Sankar, P. L., & Karlawish, J. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229137 · Cited by 112
Rezai, A. R., Ranjan, M., Haut, M. W., Carpenter, J., D’Haese, P.-F., Mehta, R. I., Najib, U., Wang, P., Claassen, D. O., Chazen, J. L., et al. (2023) · Journal of Neurosurgery · doi:10.3171/2022.9.jns221565 · Cited by 111
Kam, K., Parekh, A., Sharma, R. A., Andrade, A. G., Lewin, M. P., Castillo, B., Bubu, O. M., Chua, N. J., Miller, M. D., Mullins, A. E., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0309-5 · Cited by 111
Leibson, C. L., Long, K. H., Ransom, J. E., Roberts, R. O., Hass, S. L., Duhig, A. M., Smith, C. Y., Emerson, J. A., Pankratz, V. S., & Petersen, R. C. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.01.007 · Cited by 110
Transfer Learning for Alzheimer's Disease Detection on MRI Images
Ghahnavieh, A. E., Luo, S., & Chiong, R. (2019) · IEEE International Conference on Industry 4.0, Artificial Intelligence, and Communications Technology (IAICT) · doi:10.1109/iciaict.2019.8784845 · Cited by 111
Occupational Noise: Auditory and Non-Auditory Consequences
Sheppard, A., Ralli, M., Gilardi, A., & Salvi, R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238963 · Cited by 110
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Sleeman, K. E., Ho, Y. K., Verne, J., Gao, W., & Higginson, I. J. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-59 · Cited by 109
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 112
Transitions in Care in a Nationally Representative Sample of Older Americans with Dementia
Callahan, C. M., Tu, W., Unroe, K. T., LaMantia, M. A., Stump, T. E., & Clark, D. O. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13540 · Cited by 107
“On average, older adults with dementia accrue greater healthcare costs than persons without dementia.(3,4) A substantial proportion of these healthcare costs are attributed to hospitalizations and long-term care and to transitions between these two high-cost sites of care and the emergency department, but not all olde…”
BackgroundHome is where the future is: The BrightFocus Foundation consensus panel on dementia care
Samus, Q. M., Black, B. S., Bovenkamp, D. E., Buckley, M. J., Callahan, C. M., Davis, K. C., Gitlin, L. N., Hodgson, N. A., Johnston, D. M., Kales, H. C., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.10.006 · Cited by 107
Dementia Prevalence in Older Adults: Variation by Race/Ethnicity and Immigrant Status
Moon, H. E., Badana, A. N. S., Hwang, S.-Y., Sears, J. S., & Haley, W. E. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.11.003 · Cited by 106
Brain/MINDS: brain-mapping project in Japan
Okano, H., Miyawaki, A., & Kasai, K. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0310 · Cited by 106
Pauwels, E. K. J., Volterrani, D., Mariani, G., & Kostkiewics, M. (2014) · Medical Principles and Practice · doi:10.1159/000364873 · Cited by 103
Associations between seasonal temperature and dementia-associated hospitalizations in New England
Wei, Y., Wang, Y., Lin, C.-K., Yin, K., Yang, J., Shi, L., Li, L., Zanobetti, A., & Schwartz, J. D. (2019) · Environment International · doi:10.1016/j.envint.2018.12.054 · Cited by 101
Multimodal manifold-regularized transfer learning for MCI conversion prediction
Initiative, A. D. N., Cheng, B., Liu, M., Suk, H., Shen, D. G., & Zhang, D. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9356-x · Cited by 101
Murphy, K., O’Connor, D. A., Browning, C. J., French, S. D., Michie, S., Francis, J., Russell, G. M., Workman, B., Flicker, L. A., Eccles, M., et al. (2014) · Implementation Science · doi:10.1186/1748-5908-9-31 · Cited by 101
Lourida, I., Abbott, R. A., Rogers, M., Lang, I. A., Stein, K., Kent, B., & Thompson Coon, J. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0528-y · Cited by 100
Adverse Consequences of Unmet Needs for Care in High-Need/High-Cost Older Adults
Beach, S. R., Schulz, R., Friedman, E. M., Rodakowski, J. L., Martsolf, R. G., & James, A. E. (2018) · The Journals of Gerontology Series B · doi:10.1093/geronb/gby021 · Cited by 99
Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia
Farnsworth, B., Josefsson, M., Wåhlin, A., Nyberg, L. H., & Karalija, N. (2022) · Neurology · doi:10.1212/wnl.0000000000200255 · Cited by 99
A blood screening test for Alzheimer's disease
O’Bryant, S. E., Edwards, M., Johnson, L. A., Hall, J. R., Villarreal, A. E., Britton, G. B., Quiceno, M. E., Cullum, C. M., & Graff‐Radford, N. R. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.06.004 · Cited by 99
Huang, K.-T. (2020) · Cyberpsychology Behavior and Social Networking · doi:10.1089/cyber.2019.0269 · Cited by 98
Identifying Medicare beneficiaries with dementia
Moura, L. M. V. R., Festa, N., Price, M., Volya, M., Benson, N. M., Zafar, S. F., Weiss, M., Blacker, D., Normand, S. T., Newhouse, J. P., et al. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17183 · Cited by 98
Genetic variants in Alzheimer disease — molecular and brain network approaches
Gaiteri, C., Mostafavi, S., Honey, C. J., Jager, P. L. D., & Bennett, D. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.84 · Cited by 97
Hudomiet, P., Hurd, M. D., & Rohwedder, S. (2017) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbx169 · Cited by 97
Self-citationThe price of progress: Funding and financing Alzheimer's disease drug development
Cummings, J. L., Reiber, C. L., & Kumar, P. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.04.008 · Cited by 97
Wang, X., & Zheng, W. (2019) · The FASEB Journal · doi:10.1096/fj.201801751r · Cited by 97
Amylin at the interface between metabolic and neurodegenerative disorders
Lutz, T. A., & Meyer, U. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00216 · Cited by 97
Forbes, S. C., Holroyd-Leduc, J. M., Poulin, M. J., & Hogan, D. B. (2015) · Canadian Geriatrics Journal · doi:10.5770/cgj.18.189 · Cited by 97
Snowden, M. B., Steinman, L. E., Bryant, L. L., Cherrier, M. M., Greenlund, K. J., Leith, K. H., Levy, C. R., Logsdon, R. G., Copeland, C., Vogel, M. T., et al. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4652 · Cited by 97
3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice
Canter, R. G., Huang, W., Choi, H., Wang, J., Watson, L. A., Yao, C. G., Abdurrob, F., Bousleiman, S. M., Young, J. Z., Bennett, D. A., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0599-8 · Cited by 97
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 97
Redesigning Systems Of Care For Older Adults With Alzheimer’s Disease
Callahan, C. M., Sachs, G. A., LaMantia, M. A., Unroe, K. T., Arling, G. W., & Boustani, M. A. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1260 · Cited by 95
Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward
Hsu, D. C., & Marshall, G. A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160930112125 · Cited by 95
Stokes, A. C., Weiss, J., Lundberg, D. J., Xie, W., Kim, J. K., Preston, S. H., & Crimmins, E. M. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2831 · Cited by 94
Classics in Chemical Neuroscience: Donepezil
Brewster, J. T., Dell’Acqua, S., Thach, D. Q., & Sessler, J. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00517 · Cited by 94
Culberson, J. W., Kopel, J. J., Sehar, U., & Reddy, P. H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102001 · Cited by 95
Emerging Therapeutics for Alzheimer's Disease
Chiang, K., & Koo, E. H. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135932 · Cited by 95
Metadata
- Authors
- Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M.
- Affiliations
- RAND Corporation (US)
- University of Essex (GB)
- University of Michigan (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-04
- Volume
- 368
- Issue
- 14
- Pages
- 1326-1334
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3959992
- OpenAlex
- W2032698104
- Cited by
- 1,484
- References
- 25
- Citations by year
- 2026: 50 · 2025: 77 · 2024: 75 · 2023: 95 · 2022: 120 · 2021: 128 · 2020: 125 · 2019: 137 · 2018: 140 · 2017: 115 · 2016: 115 · 2015: 133 · 2014: 122 · 2013: 50
- FWCI
- 99.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Open Access at Essex (University of Essex) (submittedVersion)
- Funders
- National Institute on Aging (U01 AG 09740, R01AG030155, U01AG009740)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- dementia, economic burden of dementia, informal care, nursing home costs, Medicare spending, dementia prevalence, older adults, Health and Retirement Study
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Medicare, Home Care Services, Home Nursing, Humans, Longitudinal Studies, Male, Middle Aged, Nursing Homes, United States, Health Care Costs, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
